首页> 中文期刊> 《中国继续医学教育》 >腹腔镜手术后应用米非司酮治疗子宫内膜异位症研究

腹腔镜手术后应用米非司酮治疗子宫内膜异位症研究

         

摘要

Objective To analyze and study of laparoscopic surgery, the clinical effect of mifepristone in treating endometriosis.Methods In our hospital in 86 cases of endometriosis of laparoscopic surgery in 2013 April to 2014 April were patients as the research object, then they were randomly divided into observation group and control group, 43 cases in each group. The control group taking pregnant three ketene, observation group was given mifepristone, the treatment effect of the two groups were observed and compared. ResultsTwo patients in pain conditions have different degree of ease, to observe fully cured group rate was 96.45%, 82.14% in the control group,P<0.05, with statistical significance, the observation group patients did not experience elevated transaminases, 11 occurred in the control group,P<0.05, with statistical significance.Conclusion Laparoscopic operation using mifepristone in treating endometriosis has better effect, can improve the cure rate of patients, reduce transaminase elevation rate, worthy of promotion in clinical use.%目的:分析并研究腹腔镜手术后,米非司酮治疗子宫内膜异位症的临床效果。方法将我院在2013年4月~2014年4月收治的86例子宫内膜异位症腹腔镜手术后患者作为研究对象,将其随机分为观察组和对照组,每组各43例。对照组服用孕三烯酮,观察组服用米非司酮,观察并比较两组患者的治疗效果。结果两组患者的疼痛状况得到不同程度的缓解,观察组的完全治愈率为96.45%,对照组为82.14%, P<0.05,具有统计学意义;且观察组没有患者出现转氨酶升高的情况,对照组出现11例,P<0.05,具有统计学意义。结论腹腔镜手术后采用米非司酮治疗子宫内膜异位症有更好的效果,可以提高患者的治愈率,降低转氨酶升高率。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号